The effects of N-acetylcysteine and inhaled steroid on inflammatory and oxidative stress markers in chronic obstructive pulmonary disease (COPD)

Central-European Journal of Immunology

Volumn 33, Issue 3, 2008, Pages 135-141

  Van Overveld, Frans J ^a   Demkow, Urszula A ^b   Górecka, Dorota ^c   Białas Chromiec, Beata ^c   Sadowska, Anna M ^a   Goljan, Anna ^c   Kołakowski, Jacek ^c   De Backer, Wilfried A ^a   Zielinski, Jan ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Induced sputum; Inflammatory markers; Oxidative stress; Treatment

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; EOSINOPHIL CATIONIC PROTEIN; FENOTEROL; FLUTICASONE PROPIONATE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 8; IPRATROPIUM BROMIDE; SALBUTAMOL; SERINE PROTEINASE; THEOPHYLLINE; TROLOX C; TRYPTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG MECHANISM; FEMALE; HUMAN; INFLAMMATION; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE; STEROID THERAPY; TREATMENT DURATION;

EID: 44449179807     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Pauwels RA, Buist AS, Calverley PM et al. (2001): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 163:1256-1276.
2. The COPD Guidelines Group of the Standards of Care Committee of the BTS (1997): BTS Guidelines for the management of Chronic Obstructive Pulmonary Disease. Thorax 52: S1-S28.
3. Siafakas NM, Vermeire P, Pride NB et al. (1995): Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8: 1398-1420.
4. Celli B (1994): American Thoracic Society proposes standards of care for COPD. Lung & Respiration 11: 1-7.
5. Martin TR, Raghu G, Maunder RJ, Springmeyer SC (1985): The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis 132: 254-260.
6. Thompson AB, Daughton D, Robbins RA et al. (1989): Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis 140: 1527-1537.
7. Vignola AM, Campbell AM, Chanez P et al. (1993): HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 148: 689-694.
8. Thommasen HV (1985): The role of the polymorphonuclear leukocyte in the pathogenesis of the adult respiratory distress syndrome. Clin Invest Med 8: 185-194.
9. Bast A, Haenen GR, Doelman CJ (1991): Oxidants and antioxidants: state of the art. Am J Med 91: 2S-S13.
10. Jorens PG, De Jongh R, De Backer W et al. (1993): Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 148: 890-895.
11. Church MK, Young KD (1983): The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 78: 671-679.
12. Postma DS, Kerstjens HA (1999): Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 160: S66-S71.
13. De Backer WA, Amsel B, Jorens PG et al. (1996): N-Acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Med 22: 900-908.
14. Riise GC, Larsson S, Löfdahl CG, Andersson BA (1994): Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 7: 1673-1677.
15. Vachier I, Vignola AM, Chiappara G et al. (1996): ICAM-1 and GM-CSF expression in bronchial epithelial cells (BEC) from severe chronic corticosteroid-dependent asthmatics. Am J Respir Crit Care Med 153: A27.
16. Di Stefano A, Maestrelli P, Roggeri A et al. (1994): Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149: 803-810.
17. Kosmas EN, Roussou T, Ikonomou K et al. (1996): Different patterns of intercellular adhesion molecule-1 (ICAM-1) and L-selectin expression on peripheral blood mononuclear cells in patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 153: A823.
18. Keatings VM, Collins PD, Scott DM, Barnes PJ (1996): Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 153: 530-534.
19. Smith WB, Gamble JR, Clarke-Lewis I, Vadas MA (1991): Interleukin-8 induces neutrophil transendothelial migration. Immunology 72: 65-72.
20. Pober JS, Gimbrone MA Jr, Lapierre LA et al. (1986): Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor-alpha and immune interferon. J Immunol 137: 1893-1896.
21. American Thoracic Society. Statement (1995): Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: S77-S124.
22. Barnes PJ (2000): Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 342-344.
23. Kwon OJ, Jose PJ, Robbins RA et al. (1995): Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 124: 488-496.
24. Robinson D, Hamid Q, Ying S et al. (1993): Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 148: 401-406.
25. Barnes PJ, Adcock I (1993): Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436-441.
26. Woo CH, Yoo MH, You HJ et al. (2003): Transepithelial migration of neutrophils in response to leukotriene B4 is mediated by a reactive oxygen species-extracellular signal-regulated kinase-linked cascade. J Immunol 170: 6273-6279.
27. Hoffer E, Avidor I, Benjaminov O et al. (1993): N-acetylcysteine delays the infiltration of inflammatory cells into the lungs of paraquat-intoxicated rats. Toxicol Appl Pharmacol 120: 8-12.
28. Leff JA, Wilke CP, Hybertson BM et al. (1993): Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats. Am J Physiol 265: L501-L506.
29. Paggiaro PL, Chanez P, Holz O et al. (2002): Sputum induction. Eur Respir J Suppl 20: 3s-8s.
30. Efthimiadis A, Spanevello A, Hamid Q et al. (2002): Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 37: 19s-23s.
31. Re R, Pellegrini N, Proteggente A et al. (1999): Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231-1237.
32. Paglia DE, Valentine WN (1967): Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 158-169.
33. Doumas BT, Watson WA, Biggs HG (1971): Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31: 87-96.
34. Castillo MJ, Nakajima K, Zimmerman M, Powers JC (1979): Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays of serine proteases. Anal Biochem 99: 53-64.
35. Chilvers ER, Rossi AG, Murray J, Haslett C (1998): Regulation of granulocyte apoptosis and implications for anti-inflammatory therapy. Thorax 53: 533-534.
36. Thompson AB, Mueller MB, Heires AJ et al. (1992): Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis 146: 389-395.
37. Confalonieri M, Mainardi E, Della Porta R et al. (1998): Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 53: 583-585.
38. Boushey HA (1999): Glucocorticoid therapy for chronic obstructive pulmonary disease. N Engl J Med 340: 1990-1991.
39. Ha EJ, Smith AM (2003): Plasma selenium and plasma and erythrocyte glutathione peroxidase activity increase with estrogen during the menstrual cycle. J Am Coll Nutr 22: 43-51.
40. Kanaley JA, Ji LL (1991): Antioxidant enzyme activity during prolonged exercise in amenorrheic and eumenorrheic athletes. Metabolism 40: 88-92.
41. Rahman I, Skwarska E, MacNee W (1997): Attenuation of oxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 52: 565-568.
42. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ (1997): Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155: 542-548.
43. Marumo T, Schini-Kerth VB, Brandes RP, Busse R (1998): Glucocorticoids inhibit superoxide anion production and p22 phox in mRNA expression in human aortic smooth muscle cells. Hypertension 32: 1083-1088.
44. Inoue H, Aizawa H, Fukuyama S et al. (1999): Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung 177: 53-62.
45. Nathan C, Xie QW (1994): Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728.
46. Verhoeven GT, Wijkhuijs AJ, Hooijkaas H et al. (2000): Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients. Mediators Inflamm 9: 109-113.
47. Paredi P, Kharitonov SA, Leak D et al. (2000): Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162: 369-373.
48. Jaworska M, Guussen A, Schärling B et al. (1995): N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD. Pneumology 49: 539-545.
49. Nocker RE, Schoonbrood DF, van de Graaf EA et al. (1996): Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Archs Allergy Immunol 109: 183-191.
50. van Overveld FJ, Vermeire PA, De Backer WA (2000): Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors. Inflamm Res 49: 8-13.
51. Blackwell TS, Blackwell TR, Holden EP et al. (1996): In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157: 1630-1637.
52. Desaki M, Takizawa H, Kasama T et al. (2000): Nuclear factor-kappa b activation in silica-induced interleukin-8 production by human bronchial epithelial cells. Cytokine 12: 1257-1260.
53. Schubert SY, Neeman I, Resnick N (2002): A novel mechanism for the inhibition of NF-kappa B activation in vascular endothelial cells by natural antioxidants. FASEB J 16: 1931-1933.
54. Virchow JC Jr, Kroegel C, Hage U et al. (1993): Comparison of sputum ECP levels in bronchial asthma and chronic bronchitis. Allergy 48: 112-118.
55. Metso T, Venge P, Haahtela T et al. (2002): Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects. Thorax 57: 449-451.